Katrina Snow: Non-Invasive Fetal Blood Group Genotyping Is Coming to Ontario
Katrina Snow, Transfusion Safety Officer at North York General Hospital, shared a post on LinkedIn:
“Did you know that up to 40% of RhD-negative pregnancies are with fetuses who are also RhD-negative?
Very soon, non-invasive fetal blood group genotyping will be available in Ontario, which is a non-invasive way to determine the RhD status (and in some cases other red cell antigens) of the fetus.
For patients this means personalized care that can reduce their exposure to a blood product.
For healthcare this means optimization of a limited resource (RhIG).
BORN Ontario will also collect data that will support QI and evaluation.
Provincial wide implementation means there will be equity in access to this testing.
Exciting times!
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters